203 related articles for article (PubMed ID: 32306375)
1. Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis.
Radanova M; Mihaylova G; Ivanova D; Daugan M; Lazarov V; Roumenina L; Vasilev V
Clin Exp Immunol; 2020 Aug; 201(2):135-144. PubMed ID: 32306375
[TBL] [Abstract][Full Text] [Related]
2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
3. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
[TBL] [Abstract][Full Text] [Related]
4. Detection of Anti-C3b Autoantibodies by ELISA.
Radanova M; Roumenina LT; Vasilev V
Methods Mol Biol; 2021; 2227():133-139. PubMed ID: 33847938
[TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.
Vasilev VV; Noe R; Dragon-Durey MA; Chauvet S; Lazarov VJ; Deliyska BP; Fremeaux-Bacchi V; Dimitrov JD; Roumenina LT
J Biol Chem; 2015 Oct; 290(42):25343-55. PubMed ID: 26245903
[TBL] [Abstract][Full Text] [Related]
6. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Abdulahad DA; Westra J; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011 May; 13(3):R71. PubMed ID: 21548924
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
10. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
11. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis.
Heidenreich U; Mayer G; Herold M; Klotz W; Stempfl Al-Jazrawi K; Lhotta K
Lupus; 2009 Dec; 18(14):1276-80. PubMed ID: 19854810
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
[TBL] [Abstract][Full Text] [Related]
14. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
15. Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation.
Nozal P; Garrido S; Martínez-Ara J; Picazo ML; Yébenes L; Álvarez-Doforno R; Pinto S; de Córdoba SR; López-Trascasa M
BMC Nephrol; 2015 Mar; 16():40. PubMed ID: 25886501
[TBL] [Abstract][Full Text] [Related]
16. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
17. Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation.
Chen L; Yuan M; Tan Y; Zhao M
Ren Fail; 2023; 45(2):2273981. PubMed ID: 38059453
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis.
Mejia-Vilet JM; López-Hernández YJ; Santander-Vélez JI; Trujeque-Matos M; Cruz C; Carranza de la Torre CA; Espinosa-Cruz V; Espinosa-González R; Uribe-Uribe NO; Morales-Buenrostro LE
Lupus; 2020 Apr; 29(4):371-378. PubMed ID: 32041505
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
[TBL] [Abstract][Full Text] [Related]
20. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
